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Abstract: Acetylcholinesterase (AChE) activities in different brain parts were determined 
quantitatively in rats treated with huperzine A, soman, and huperzine A followed by 
soman, using histochemical and biochemical methods. Following soman intoxication (1.2 
x LD50, i.m.), AChE activity was decreased to 30-80% of control values depending on the 
brain structure. The most sensitive area was the frontal cortex and the most relatively 
resistant was ncl. ruber. Huperzine A treatment only caused a change in AChE activity 
varying from 70 to 100 % of control values. In rats pretreated with huperzine A and 
intoxicated with soman, AChE activity was significantly higher than that observed after 
soman. In these animals, survival of rats pretreated with huperzine was observed while 
the mortality of unpretreated animals was near to 80 %. The results suggest that huperzine 
A is good candidate for further study for clinical use as a prophylactic drug against nerve 
agent poisoning.    
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1. Introduction  
 
Nerve agents belong to the most toxic organophosphorus cholinesterase inhibitors. They can be 
used as chemical warfare agents and, they can be (and h ve been) misused by terrorists. The 
countermeasures against their effect (i.e. prophylaxis nd treatment) are of high importance [1-4]. 
Protection against the inhibition of acetylcholinesterase (AChE, EC 3.1.1.7) using reversible 
cholinesterase inhibitors is the most common approach to pharmacological prophylaxis. The 
administration of present antidotes or scavengers such as cholinesterase preparations to prevent the 
effects of OP is also possible [1,5,6]. As for as protection against cholinesterase inhibition, 
pyridostigmine seems to be a most common prophylactic drug. However, its low central effects and 
relative high toxicity are disadvantages of its use. Therefore a search for new prophylactics was 
performed. 
Huperzine A is reversible and selective AChE inhibitor compared to BuChE and is a more potent 
inhibitor of AChE than pyridostigmine. The review of Jiang et al. [7] represents a comprehensive 
documentation of the progress in the studies on huperzine A covering the period 1999-2002. It appears 
to be a selective inhibitor of red cell AchE, while pyridostigmine or physostigmine additionally inhibit 
plasmatic butyrylcholinesterase (BuChE, EC 3.1.1.8) in guinea-pigs [8,9]. Since pyridostigmine does 
not penetrate into the brain, it does not afford protection against seizures and subsequent 
neuropathology induced by an OP agent such as soman. Besides, huperzine has also been successfully 
tested for pretreatment of OP poisoning [10,11]. 
Huperzine A was tested for its prophylactic potential [12-17] and by means of a dynamically 
working in vitro model using AChE from immobilized human erythrocytes. The model predicts that 
inhibitors with a faster dissociation constant such as huperzine may be superior in case of very 
effective poisons such as soman [18]. However, there is a lack of information dealing with selective 
effect of huperzine especially on the AChE in the brain structures. It is known that the brain is well-
organized and complex organ containing different levels of neuromediators and relevant enzymes in 
various structures of the brain. AChE activity varies a minimum 14-fold between striatum and 
cerebellum [19]. In prophylactic studies, AChE activity was determined in the whole brain 
homogenate. Some our results showed differential AChE inhibition in various brain regions, ranging 
from 15 to 86% following intoxication with soman [20]. Thus, the activity determined in the whole 
brain homogenate can be considered as a “mean” of the activities in different brain structures. It is 
difficult to correlate biochemical results which are not defined structurally as those in histochemical 
studies. However, this approach (comparison of these r ults) was used [20] and showed that it is 
possible and it would be interesting approach allowing more detailed explanation of action of nerve 
agents as well as their therapeutic influencing. Therefore (on the basis of above mentioned studies), 
prophylactic effects of huperzine A against soman using determination of AChE activity 
(histochemical and biochemical) in selected rat brain structures was studied.  
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Following soman treatment, five from six animals died within 30 min after soman poisoning. 
Typical symptoms of poisoning – salivation, disturbed ventilation and convulsions – were observed in 
all animals in this group. After administration of huperzine A, fine tremor was observed occuring 10-
30 min post administration, as well as in a group of animals pretreated with huperzine A and 
intoxicated with soman. All animals in these two grups showed practically unchanged ventilation and 




The data on AChE activity in the brain areas are presented in Table 1. AChE activity varied from 
high (F.ret, Th, Hipp) to low (FC, NR) values.  
 
Table 1. Histochemical (H) and biochemical (B) results of AChE activities following 
Huperzine A and soman treatment. 
Group CONTROL SOMAN HUPERZINE HUPERZINE+SOMAN 
Area H B H B H B H B 
FC 
a 181.1 253.0±13.3 53.4 70.1±10.5 125.6 190.2±12.1 83.8 121.4±12.4 
% 100 100 29.V 27.7c 69.3 75.2a,d 46.3 48.0 b,c,d 
Hipp 
a 221.45 301.6±15.3 89.5 135.5±14.7 165.9 241.3±14.6 112.5 158.2±13.8 
% 100 100 40.4 44.9 74.9 80.0a,d 50.8 52.5 b,d 
HTh 
a 203.4 262.0±14.3 66.8 92.7±13.8 184.2 249.1±14.2 154.7 209.6±14.3 
% 100 100 32.8 35.4c 90.6 95.0d 76.0 80.0 b,c,d 
NR 
a 187.9 251.3±15.3 141.05 198.3±14.3 198.35 261.4±13.9 176.4 246.0±14.1 
% 100 100 75.1 78.9c 105.6 104.0 93.9 97.9 c 
F.ret 
a 226.9 385.0±13.3 63.7 101.5±12.3 176.5 269.5±12.9 147.4 261.8±13.5 
% 100 100 28.I 26.4c 77.8 70.0a 65.0 68.0 b,c 
DSep 
a 192.7 251.2±12.3 57.7 89.6±10.8 152.3 213.5±13.0 154.7 205.8±13.1 
% 100 100 29.IX 35.7c 79.0 85.0a 80.3 81.9 b,c 
Th 
a 223.9 325.3±14.0 74.1 114.8±13.7 214.1 322.0±13.5 172.6 253.2±14.2 
% 100 100 33.1 35.3c 95.6 99.0d 77.1 77.8b,c,d 
For biochemical examinations, the results are means with their standard errors (n=6) (AChE activity in 
µmol/60 min/kg) and percent activity expression (%). 
For histochemical examinations, the results are means (AChE activity in pixel density, n=3) and percent 
activity expression (%). 
BIOCHEMICAL RESULTS: All control values are significantly different from group soman (all parts) 
(p<0.05). The letters indicate significant differenc  for other experimental groups: (NR – nucleus rube  
from amygdala, FC – frontal cortex,  DSep – dorsal septum, HTh – hypothalamus, Hipp – hippocampus, Th 
– thalamus, F.ret  – pontomedullar area, mostly reticular formation containing nucleus gigantocellularis and 
others). 
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Administration of soman caused strong inhibition of AChE in all areas studied. Percentual 
inhibition was highest in F.ret and FC, which had about 30 % of the control activity. For huperzine 
treatment, the highest AChE inhibition was observed in F.ret and FC areas (about 70-75 % of controls). 
Lower inhibition of AChE observed in the rest brain structures and in NR, AChE inhibition was not 
detected.  
Following pretreatment with huperzine and soman intoxication (HUPERZINE+SOMAN group), 
AChE activity in all brain parts examined was lower in comparison with huperzine treatment only 
(HUPERZINE group). However, the activities were higher in all brain parts compared with soman 
intoxication only (SOMAN group), and they were statistically significant for NR, F.ret, and DSep, 
respectively.  
 
2.3 Histochemical  
 
The histochemical results showed a similar picture o that of the biochemical examination (Table 
1). The area most sensitive to soman was FC and Dsep (about 30 % of control values), and the most 
resistant was NR (75 %). The other soman treated brain regions had about 30-40 % of the control 
values. Histochemical inhibition values following administration of huperzine only matched most 
closely in the FC. The structures most resistant to huperzine seems to be NR. Histochemical pictures of 
three areas, the relatively sensitive FC, and F.ret and Hipp are shown in Figures 1-3.  The quantitative 
evaluation following intoxication with soman pretreat d with huperzine is also shown also in Figures 
1-3, where it can be seen that AChE inhibition in all p rts has had relatively same tendency as observed 
for biochemical examinations. According to biochemical results, AChE inhibitions following 
huperzine administration (HUPERZINE group) and soman intoxication pretreated with huperzine 
(HUPERZINE+SOMAN group) are very similar. However, after quantitative histochemical evaluation, 
the activities are shifted to lower densities and frequency of pixels is different.  
 
Figure 1. Top: Microphotography of 20 µm sections of the rat brain (reticular formation, 
ncl. gigantocellularis, position is marked by arrow) following huperzine, soman and 
huperzine followed by soman administration.  1 - contr l, 2 - Huperzine A, 3 – soman, 4 
– Huperzine A + soman. Magnification: 40x, Staining: AChE [22]. 
    
1                                                2                                            3                                              4 
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Figure 2. Top: Microphotography of 20 µm sections of the rat brain (hippocampus) 
following huperzine, soman and huperzine followed by soman administration. 5 - control, 
6 - Huperzine A, 7 – soman, 8 – Huperzine A + soman. Magnification: 40x, Staining: 
AChE [22]. 
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Figure 3. Top: Microphotography of 20 µm sections of the rat brain (frontal cortex) 
following huperzine, soman and huperzine followed by soman administration.  9 – 
control, 10 - Huperzine A, 11 – soman, 12 – Huperzine A + soman. Magnification: 40x, 
Staining: AChE [22]. 
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Correlation between results obtained using histochemical and biochemical methods 
 
The comparison of percentage of residual AChE activity after administration of soman, huperzine 
and huperzine followed by soman in 7 brain regions (Figure 4) shows a good correlation between 




Huperzine A is considered and studied with respect to prophylaxis in vitro and in vivo [11,14,16].     
In general, reversible inhibitors including huperzine protect organism from the acute toxicity of lethal 
doses of the nerve agents such as sarin or soman [1,5,10,11,13] as it was also demonstrated in our 
experiments.   
At the light of its particular inhibitory affects on the brain AChE activity, huperzine, compared to 
the other drugs, seems to be the optimal candidate to be used as pretreatment against OP poisoning 
[8,9] as demonstrated in guinea-pigs. In preventing he lethality of nerve agents, huperzine was 
effective compared with other reversible cholinesteras  inhibitors (Tacrine, donepezil, rivastigmine, 
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etc.) [17]. The protective effects against soman toxicity of huperzine were demonstrated also in 
primates [10]. 
 
Figure 4. Comparison of results obtained by histochemical and biochemical methods 
(percentual values) following administration of soman, huperzine and soman pretreated 
with huperzine.   
Fig. 4: Comparison of results obtained by 
biochemical and histochemical methods 
(percentual values)
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The results of Grunwald et al. [12] suggest that the protection of mice from soman poisoning by 
huperzine was achieved by temporary sequestering the active site region of the physiologically 
important AChE. In this connection, it is of interest that the main cholinergic pathways in the brain 
cholinergic system are represented i.a by septal nuclei, thalamus, cortex and hippocampus [26]. Some 
of these structures were studied in our paper and their influencing either by soman or huperzine was 
different. The not-uniform AChE inhibition in the different brain structures following untreated 
intoxication with nerve agents in rats and guinea-pigs [27,28] was demonstrated. This non-uniform 
inhibition suggests that some brain structures more sensitive to huperzine or OP than others can be 
functionally important for toxic/prophylactic action. The pontomedullar area seems to be the important 
structure because of its role in the respiratory control through the regulatory centers for respiration [29] 
in this brain part. Respiration is under cholinergic innervation [29,30]. The depression of central 
respiratory control centers in the pontomedullar area is considered as a primary event leading to death 
[31-33]. The highest AChE inhibition in this structre either by soman or huperzine i  vivo supports a 
hypothesis that AChE inhibition here could be a cause of an interuption of cholinergic pathways 
controlling ventilation function. This not-uniformity can be explained by fine differences of huperzine 
action not only on the enzyme (AChE) activity but also by its different action on a structural level. 
Nucleus gigantocellularis contained in pontomedullar area and AChE here could be a key target for a 
survival or death of animals intoxicated with soman. On the other hand, AChE activity in NR was 
relatively unchanged in groups pretreated with huperzin  only and huperzine followed by soman 
Int. J. Mol. Sci. 2007, 8                  
          
 
1172
intoxication. This resistancy supports an idea about different penetration of drugs/poisons into various 
brain areas.   
These results suggest that huperzine is an important drug employed not only in the treatment of 
Alzheimer disease [26] but it is good candidate for further study for clinical use as prophylaxis against 
nerve agents. Its generally known effect – protection of AChE against its inhibition by soman – would 
have different importance for various brain structures. Our results underline the importance of 
pontomedullar brain area in this connection. 
 
3. Experimental Section 
 
3.1 Animals  
 
Female Wistar rats (VELAZ Prague), weighing 200-220 g, were used in this study. The animals 
were divided into groups of three (histochemical) and six (biochemical) animals each. Rats were 
housed in the Central Vivarium of the Faculty of Military Health Sciences under veterinary control. Al 
the experiments were performed under permission and supervision of the Ethics Committee of the 
Faculty of Military Health Sciences, Hradec Kralove (p rmission No 153/06) according to § 17 of the 
Czech law No 207/2004, permission of responsible person 0001/94 – M 699.    
 
3.2 Chemicals  
 
Soman was obtained from the Military Technical Institute of Protection (Brno, Czech Republic). It 
was of minimally 99% purity and stored in glass ampullas (1 mL). The solutions of the agents for 
experiments were prepared before use. Huperzine A was obtained from Sigma Aldrich Gmbh (Division 
of Czech Republic) as well as other chemicals of analytical purity. 
 
3.3 Intoxication and pretreatment 
 
CONTROL GROUP: The animals were injected with saline i.p. and 30 min later, they were injected 
once again with saline i.m. (0.1 mL/kg). The decapitation and brain removal (sampling) was realized 
30 min after the last saline injection. 
SOMAN GROUP: The animals were injected with saline .p. and 30 min later, soman was 
administered i.m. in a dose of 1.2 x LD50,  i.e. 84.0 µg/kg;  30 min after the injection/at the time of 
death, the animals were decapitated, the brain was removed and used for histochemical or biochemical 
examinations. 
HUPERZINE GROUP: The animals were injected i.p. with Huperzine A (500 µg/kg) and 30 min 
later, they were injected with saline i.m. The dose f Huperzine A as well as the route of administration 
was used on the base of previously published results [12]. The sampling was performed 30 min after 
the injection of saline. 
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HUPERZINE+SOMAN GROUP: the animals were pretreated with Huperzine as it is described in 
the previous group. 30 min later, the animals were intoxicated with soman and decapitated 30 min after 
the soman injection.   
 
3.4 Histochemical determination of AChE  
 
Removed brains were rapidly frozen and cut into a serie  of 20 µm sections in a cryostat. For 
neuroanatomical mapping according to the rat brain atlas [21], AChE detection [22] was used. The 
Karnovski-Roots method is based on hydrolysis of arti icial substrate acetylthiocholine (the same as in 
biochemical examination) and detection of the released reaction product (thiocholine). For digital 
microphotography, Olympus BX51 light microscope equipped with CCD was used. 
Quantitative evaluation was made using software 3D Doctor [23,24]. The picture was transposed to 
a gray scale with density distribution (expressed in pixels) ranging from 0 to 255. Lower pixel number 
indicates high activity, higher number shows inhibition. Because the density is of linear scale, the 
difference (255 - determined density) gives us information on the AChE activity. This pixel density 
was compared in control and intoxicated animals for each structure examined in absolute and relative 
(%) values. 
We selected the following sections and groups of nuclei to compare quantitative histochemistry 
with biochemical determination of AChE: ncl. ruber (NR) – section at the level 5,8 dorsally from 
bregma; frontal cortex (FC) – the level of 2.2 mm rost ally to bregma, containing areas F1, F2, F3; 
dorsal septum (DS) – the level of bregma, including lateral septal ncl – dorsal and intermediate parts; 
hypothalamus (HTh), 2.8 mm dorsally to bregma, including ventromedial and dorsomedial 
hypothalamic nuclei, perifornical, arcuate, periventricular and supraoptic nuclei, tuber cinereum, dorsal 
and lateral hypothalamic areas; hippocampus (Hipp), 3.5 mm dorsally to bregma; medial thalamus (Th) 
2,8mm dorsally from bregma including mediodorsal nuclei, intermediodorsal, paraventricular, 
paracentral, central medial and centrolateral nuclei; ponto-medullar area (F.ret, section at the level of 
13 mm dorsally to bregma, we evaluated only ncl. gigantocellularis as representative by AChE activity, 
its size, and function. The distance from bregma and terminology of nuclei are quoted from Paxinos 
and Watson [21].  
 
3.5 Biochemical determination of AChE  
 
The brain parts (NR, FC, DS, HTh, Hipp, Th, F.ret) were prepared and frozen. After thawing, tissue 
was homogenized (1:10, distilled water, Ultra Turrax homogenizer) and homogenates were used for 
enzymatic analysis. AChE activity was determined using the method of Ellman et al. [25]. 
Acetylthiocholine was used as substrate (Tris-HCl buffer pH 7.6). UVIKON 752 spectrophotometer 
was used for determination of absorbancy at 412 nm. The activity was expressed as µmol of substrate 
hydrolyzed/(60 min.kg) wet weight tissue or as % of c ntrol values.  
 
3.6 Statistical evaluation  
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Enzyme activities were expressed as a mean ±SD or % of control values (means only) and statistical 
differences were tested by t-test.  Transformation of the curves and their equations and correlation 




The authors are indebted to Mrs J. Ellingerova and J. Uhlirova for skilful technical assistance.  
Financial support of the Ministry of Defence (grant No OPUOFVZ 200603) and Grant Agency of 
Charles University (grant No GA UK 82/2005) is gratefully acknowledged.  
 
References and Notes 
 
1. Bajgar, J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis 
and treatment. Adv. Clin. Chem. 2004, 38, 151-216. 
2. Eyer, P. The role of oximes in the menagement of organophosphorus pesticides poisoning. 
Toxicol. Rev. 2003, 22, 165-190. 
3.  Rotenberg, J.S.; Newmark, J. Nerve attacks on children: diagnosis and management. Pediatrics 
2003, 112, 648-658. 
4. Wiener, S.W.; Hoffman, R.S. Nerve agents: a comprehensive review. J. Int. Care. Med. 2004, 19, 
22-37. 
5. Bajgar J. Prophylaxis against organophosphorus poisoning. J. Med. Chem. Def. 2003, 1, 1-15. 
6. Bajgar, J.; Fusek, J.; Sevelova, L.; Kassa, J. Complex prophylaxis against nerve agent 
intoxication. In: The Eighth International Symposium on Protection against Chemical and 
Biological Warfare Agents, Goteburg, Sweden, 2-6 June 2004, Abstracts; 2004;  p. 51. 
7. Jiang, H.L.; Luo, X.M.; Bai, D.L. Progress in clinical, pharmacological, chemical and structural 
biological studies of huperzine A: a drug of traditional Chinese medicine origin for the tratment of 
Alzheimer´s disease. Curr. Med. Chem. 2003, 10, 2231-2252. 
8. Lallement, G.; Foquin, A.; Dorandeu, F.; Baubichon, D.; Aubriot, S.; Carpentier, P. Subchronic 
administration of various pretreatments of nerve agnt poisoning. I. Protection of blood and 
central cholinesterases, innocuousness towards blood- rain barrier permeability. Drug Chem. 
Toxicol. 2001, 24, 151-164. 
9. Lallement, G.; Foquin, A.; Dorandeu, F.; Baubichon, D.; Carpentier, P. Subchronic administration 
of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity. 
Drug Chem. Toxicol. 2001, 24, 165-180. 
10. Lallement, G.; Demoncheaux, J.P.; Foquin, A.; Baubichon, D.; Galonnier, M.; Clarencon, D.; 
Dorandeu, F. Subchronic administration of pyridostigmine or huperzine to primates: compared 
efficacy against soman toxicity. Drug Chem. Toxicol. 2002, 25, 309-320. 
11. Lallement, G.; Taille, V.; Baubichon, D.; Carpenti r, P.; Collombet, J.M.; Filliat, P.; Foquin, A.; 
Four, E.; Masqueliez, C.; Testylier, G.; Tondulli, L.; Dorandeu, F. Review of the value of 
huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002, 23, 1-5. 
Int. J. Mol. Sci. 2007, 8                  
          
 
1175
12. Grunwald, J.; Raveh, L.; Doctor, B.P.; Ashani, Y. Huperzine-A as a pretreatment candidate drug 
against nerve agent toxicity. Life Sci. 1994, 54, 991-997. 
13.  Albuquerque, E.X.; Pereira, E.F.R.; Aracava, Y.;  Fawcett, W.P.; Oliveira, M.; Randall, W.R.; 
Hamilton, T.A.; Kan, R.K.; Romano, J.A.; Adler, M. Effective countermeasures against poisoning 
by organophosphorus insecticides and nerve agents. Proc. Nat. Acad. Sci. USA 2006, 103, 13220-
13225. 
14. Ashani, Z.; Peggins, J.O.; Doctor, B.P. Mechanism of inhibition of cholinesterase by Huperzine A. 
Biochem. Biophys. Res. Commun. 1992, 184, 719-726. 
15. Gordon, R.K.; Haigh, J.R.; Garcia, G.E.; Feaster, S.R.; Riel, M.A.; Lenz, D.E.; Aisen, P.S.; 
Doctor, B.P. Oral administration of pyridostigmine bromide and huperzine A protects human 
whole blood cholinesterases from ex in vivo exposure to soman. Chem-Biol. Interact. 2005, 157, 
239-246. 
16. Patocka, J.; Kassa, J. Huperzine A – prospective prophylactic antidote against organophosphate 
warfare agent poisoning. ASA Newslett. 1999, 99-2, 16-19. 
17. Wang, R.; Yan, H.; Tang, X.C. Progress in studies of huperzine A, a natural cholinesterase 
inhibitor from Chinese herbal medicine. Acta Pharmacol. Sin. 2006, 27, 1-26. 
18. Eckert, S.; Eyer, P.; Muckter, H.; Worek, F. Kinetic analysis of the protection afforded by 
reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic 
organophosphorus compounds. Biochem. Pharmacol. 2006, 72, 344-357. 
19. Gupta, R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and 
carbamates. Toxicol. Mech. Methods  2004, 14, 103-143. 
20. Bajgar, J.; Hajek, P.; Slizova, D.; Krs, O.; Fusek, J.; Kuca, K.; Jun, D.; Bartosova, L.; Blaha, V. 
Changes of acetylcholinesterase activity in different brain areas following intoxication with nerve 
agents: biochemical and histochemical study. Chem-Biol. Interact. 2007, 165, 14-21.  
21. Paxinos, G.; Watson, C. The rat brain in stereotactic coordinates. Academic Press: New York, 
1987. 
22. Lojda, Z.; Gossrau, R.R.; Schiebler, T.H. Enzyme Histochemistry – A Laboratory Manual. 
Springer: New York, 1979. 
23. Benali, A.; Leefken, I.; Eysel, U.; Weile, E. Acomputerized image analysis system for 
quantitative analysis of cells in histological brain sections. J. Neurosci. Meth. 2003, 125, 33-43.  
24. Hammond, P.I.; Jelacic, T.; Padilla, S.; Brimijoin, S. Quantitative, video-based histochemistry to 
measure regional effects of anticholinesterase pesticides in rat brain. Anal. Biochem. 1996, 241, 
82-92. 
25. Ellman, G.L.; Courtney, D.K.; Andres, V.; Featherstone, R.M. A new and rapid colorimetric 
determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88-95. 
26. Giacobini, E.; Pepeu G. Cholinesterases in human br in: the effect of cholinesterase inhibitors on 
Alzheimer´s disease and related disorders. In The Brain Cholinergic System in Health and 
Disease; Informa Healthcare: Abingdon, UK, 2006; pp. 235-264. 
27. Gupta, R.C.; Patterson, G.T.; Dettbarn, W.D. Biochemical and histochemical alterations following 
acute soman intoxication in the rat.  Toxicol. Appl. Pharmacol. 1987, 87, 393-402. 
Int. J. Mol. Sci. 2007, 8                  
          
 
1176
28. Shih, T.-M.; Kan, R.K.; McDonough, J.H. In vivo cholinesterase inhibitory specificity of 
organophosphorus nerve agents. Chem-Biol. Interact. 2005, 157, 158, 293-303. 
29. Pope, C.N. Central nervous system effects and neurotoxicity. In Toxicology of Organophosphate 
and Carbamate Compounds; Elsevier-Academic Press: Amsterdam, 2006; pp. 271-291. 
30. Sungur, M.; Guven, M. Intensive care management of organophosphate insecticide poisoning. 
Crit. Care 2001, 5, 211-215. 
31. Goswany, R.; Chaudhuri, A.; Mahashur, A.A. Study of respiratory failure in organophosphate and 
carbamate poisoning. Heart Lung 1994, 23, 466-472. 
32.  Stewart, W.C.; Anderson, E.A. Effect of a cholinesterase inhibitor when injected into the medulla 
of the rabbit. J. Pharmacol. Exp. Ther. 1968, 162, 309-318. 
33.  Bird, S.B.; Gaspari, R.J.; Dickson, E.W. Early death due to severe organophosphate poisoning is a 
centrally mediated process. Acad. Emerg. Med. 2003, 10, 295-298. 
 
© 2007 by MDPI (http://www.mdpi.org). Reproduction is permitted for noncommercial purposes. 
